—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Vaxcyte Inc (PCVX) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 35 out of 100 (momentum 67 · quality 4), as of 2026-11-03.
  • Signal: Pullback inside an uptrend stack — Trades -1.5% vs the 50-day and +6.2% vs the 200-day average, 33.2% below the 52-week high and +52% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Vaxcyte Inc trades 1.5% below its 50-day and 6.2% above its 200-day moving average. (as of 2026-11-02)

Vaxcyte is a clinical-stage vaccine developer working on conjugate and protein vaccines aimed at bacterial infections. Its lead programmes target pneumococcal disease, with wider-valency candidates meant to cover more strains than existing shots, alongside earlier-stage work on strep, gum disease and dysentery.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the PCVX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pullback inside an uptrend stack

Trades -1.5% vs the 50-day and +6.2% vs the 200-day average, 33.2% below the 52-week high and +52% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the PCVX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on PCVX?

Pullback inside an uptrend stack — Trades -1.5% vs the 50-day and +6.2% vs the 200-day average, 33.2% below the 52-week high and +52% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is PCVX above its 50-day and 200-day moving averages?

As of 2026-11-02, Vaxcyte Inc trades -1.5% below its 50-day and +6.2% above its 200-day average, with the 20-day -5.8% away.

How far is PCVX from its 52-week high?

33.2% below the 52-week high and 52% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.